Ford et al.
New article in NEJM supports the role of increased intestinal permeability in the pathophysiology of IBS.
Increased intestinal permeability and tight junctions alterations trigger an inflammatory reaction which alters visceral neuromuscular function, leading to IBS symptoms like abdominal pain and diarrhea or constipation.
Ford et al. N Engl J Med 2017; 376:2566-78 - http://www.nejm.org/doi/10.1056/NEJMra1607547
Gelsectan® is a mucoprotector with components of natural origin, that reinforces the mucosa against pathologic aggression and helps restore its normal function, thus contributing to improve IBS symptoms.
Gelsectan is a medical device, for more information click here: http://noventure.com/gelsectan
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.